| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
H5
|
Xiaoping Su
|
Mar 01, 2024
|
|||||
| GSE252936 |
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor (scATAC-Seq)
|
6 | Xiaoping Su | Mar 01, 2024 | ||||
| GSE252938 |
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor
|
34 | Xiaoping Su | Mar 01, 2024 |
